We’re revolutionizing
healthcare startup investing
You’re invited.

Join the Community
Sign up to view exclusive deals on the Bioverge platform.


Realized Net IRR 1


Realized MOIC 1


Accredited Investors in the Bioverge Network1
You, too, can benefit from healthcare venture capital at Bioverge. We provide individuals access to invest alongside institutions on our easy-to-use platform. Our experienced investment team leverages deep domain expertise and proprietary deal access to help drive compelling risk-adjusted returns.
“This is the first time I’ve been able to access opportunities of this caliber in commercial real estate.”
Seth, Chicago, Illinois
Cadre Direct Access Fund Investor
“This is the first time I’ve been able to access opportunities of this caliber in commercial real estate.”
Seth, Chicago, Illinois
Cadre Direct Access Fund Investor
Sign Up
Sign Up
Sign Up
Sign Up

Join a world-class community and invest alongside us and other to venture funds.

Three ways you can invest with Bioverge

Access Funds
Invest in diversified portfolios of emerging healthcare startups with a single investment.
Learn More
Select individual investment opportunities on a deal-by-deal basis. Become a member to see available opportunities.
Learn More
Thematic Funds
Similar to Access Funds, but focused on specific technology or disease areas such as longevity, cancer, digital health, and more.
Learn More

Diversify with the Bioverge Access Fund

Own a diversified portfolio of premier startups tackling some of healthcare’s biggest challenges with a single investment, each carefully selected for their potential to impact the world and generate outsized financial returns.

Why healthcare venture capital?

Why Now?
The life sciences revolution is the venture capital opportunity of our lifetimes. At the convergence of healthcare + technology, unprecedented innovation is unfolding that stands to radically reshape and transform the future of medicine over coming decades.
Why Bioverge?
We enable you to invest in startups that are transforming healthcare and directly impact the causes you care about most. Leveraging our deep domain expertise and expansive network, we provide you access to premier healthcare startups and offer specialized support to our growing portfolio.
Why You?
Venture capital has historically generated outsized returns and become a staple of diversified, professional investment portfolios. If you’re not investing in venture capital, you may be leaving money on the table. Answer just a few qualifying questions to join our community of investors and you could change your financial trajectory.
Who can invest in Bioverge Funds?

In order to invest in Bioverge Funds, investors must meet the criteria of being an accredited investor.

What is an accredited investor?

“Accredited investor” has been defined by the Securities and Exchange Commission (SEC) as a test to determine who is eligible to participate in certain private capital market offerings. Generally an individual person is an accredited investor if they: (1) had an income of $200,000 over the last two years (or $300,000 jointly with a spouse or spousal equivalent) and reasonably expect to satisfy the same criteria in the current year, (2) have a net worth of over $1,000,000, either alone or together with a spouse or spousal equivalent (excluding the person’s primary residence) or (3) hold a Series 7, Series 82, or Series 65 financial services license and is in good standing. An individual must be an accredited investor to invest with Bioverge.

Can international investors participate?

Yes, international investors can participate in Bioverge Funds. Our offerings are conducted under the SEC's Regulation D, Rule 506, which allows for participation from both domestic and international investors, provided that they are accredited and comply with the regulations of their respective jurisdictions.

I am investing through a business entity (i.e. a trust, LLC, partnership, or corporation). How does an entity qualify as an accredited investor?

In addition to qualifying as an individual, there are other categories of accredited investors which will satisfy the SEC’s definitions: (1) any entity in which all of the equity owners are accredited investors, or (2) any trust, with total assets in excess of $5 million, not formed specifically to purchase the subject securities, whose purchase is directed by a sophisticated person, or (3) certain entity with total investments in excess of $5 million, not formed to specifically purchase the subject securities.

1 Data as of March 31, 2023. Accredited Investors is based on accredited investors in the Bioverge Network. Realized Net IRR (internal rate-of-return) is net of fees and expenses. MOIC (multiple-on-invested capital) is gross, before taking into account fees and expenses. Realized Net IRR and Realized MOIC are realized values based on the performance of all exits and write-downs or liquidation events, and are limited to companies within our portfolio that have had an exit event or have been shut down, or are otherwise no longer operating. Realized Net IRR and Realized MOIC are based on distributions calculated at the time of transaction close, and include escrows and amounts receivable at a future date but do not include contingent compensation that may not be realized. Realized Net IRR and Realized MOIC may be higher or lower due to the impact of market fluctuations for publicly held securities and the impact of the timing of distributions. Results are not audited. Past performance is not indicative of future results.  Back
Important Disclosures
Private Securities
Investments in private offerings are speculative and involve a high degree of risk. Investments in private offerings are not bank deposits and therefore are not insured by the FDIC or guaranteed by any other party. Investors must be qualified as an accredited investor to participate in private offerings and you may be required to verify your status as an accredited investor. No securities commission or regulatory authority has recommended or approved any investment or the accuracy or completeness of any of the information or materials provided by or through us.
Not Advice
This communication is not to be construed as investment, tax, or legal advice in relation to the relevant subject matter; investors must seek their own legal or other professional advice before making any investment to determine whether an investment is suitable for them.
Performance Not Guaranteed
Past performance is no guarantee of future results. Any historical returns, expected returns, or probability projections are not guaranteed and may not reflect actual future performance.
Risk of Loss
All investments involve a high degree of risk and may result in partial or total loss of your investment.
Liquidity Not Guaranteed
Investments offered by Bioverge are illiquid and there is never any guarantee that you will be able to exit your investments on the Secondary Market or at what price an exit (if any) will be achieved.
Investors shown are investors in one or more of the following: (a) Access Funds, (b) Deal-by-Deal investments, (c) Thematic Funds, or (d) are shareholders of Bioverge, Inc.
Not an Offer to Sell or Solicitation to Buy
The information presented on this Website does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities of Bioverge. Any such offer would only be made through of a prospectus, private placement memorandum, subscription agreement or similar documents. This Website is subject to material updating, revision and further amendment.
Conduct Your Own Due Diligence
This information is not intended to provide the sole basis for your evaluation of Bioverge. You should conduct your own due diligence of Bioverge and independently verify the information contained below before proceeding further with any investment in or other transaction with Bioverge. Our officers will make themselves available to answer any questions that you may have regarding our company, its business, operations and prospects should you decide to proceed further with an investment or other transaction with Bioverge.
Forward Looking Statements
The information set forth below includes statements, estimates, projections with respect to our anticipated future performance and other forward-looking statements, which are subject to risks, uncertainties and assumptions. In some cases, you can identify these statements by forward-looking words such as “may”, “might”, “will”, “should”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “future” or “continue”, the negative of these terms and other comparable terminology. Such forward-looking statements are based on current plans, estimates and expectations and are made pursuant to the Private Securities Litigation Reform Act of 1995. These statements, estimates and projections are based upon various assumptions that we made concerning our anticipated results and industry trends, which may or may not occur. We are not making any representations as to the accuracy of these statements, estimates or projections. Our actual performance may be materially different from the statements, estimates or projections set forth below. We are under no duty to update any of these forward-looking statements to conform them to actual results or revised expectations. Back